OBJECTIVE: To evaluate the diagnostic yield of investigating dyspepsia with oesophagogastroduodenoscopy (OGD) with or without mucosal biopsy. DESIGN: Retrospective service evaluation study. SETTING: Two teaching hospitals: The Royal Hallamshire Hospital and Northern General Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, UK. PATIENTS: 500 patients, 55 years of age and over, who underwent OGD to investigate dyspepsia were included. The study period included a 3-month window. All OGDs were performed on an outpatient basis. INTERVENTIONS: Data were extracted from electronic OGD records within the study period. MAIN OUTCOME MEASURES: Diagnostic yield provided by endoscopic examination and histological assessment. RESULTS: 378 patients (75.6%) were reported to have some form of endoscopic abnormality, and 417 patients (83.4%) had biopsies taken. The most common findings at OGD were gastritis (47.2%) and oesophagitis (24.4%). Oesophagogastric malignancy was seen in 1%. Diagnoses made endoscopically or histologically that would not have been appropriately managed by empirical therapies were seen in 16.2%. CONCLUSION: OGD in dyspepsia influences patient management in approximately one-sixth of cases. However, the majority of patients are sufficiently managed with Helicobacter pylori testing and eradication and/or a trial of proton pump inhibitor therapy. Further non-invasive approaches are needed to identify patients who need endoscopy for biopsy or therapy.
OBJECTIVE: To evaluate the diagnostic yield of investigating dyspepsia with oesophagogastroduodenoscopy (OGD) with or without mucosal biopsy. DESIGN: Retrospective service evaluation study. SETTING: Two teaching hospitals: The Royal Hallamshire Hospital and Northern General Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, UK. PATIENTS: 500 patients, 55 years of age and over, who underwent OGD to investigate dyspepsia were included. The study period included a 3-month window. All OGDs were performed on an outpatient basis. INTERVENTIONS: Data were extracted from electronic OGD records within the study period. MAIN OUTCOME MEASURES: Diagnostic yield provided by endoscopic examination and histological assessment. RESULTS: 378 patients (75.6%) were reported to have some form of endoscopic abnormality, and 417 patients (83.4%) had biopsies taken. The most common findings at OGD were gastritis (47.2%) and oesophagitis (24.4%). Oesophagogastric malignancy was seen in 1%. Diagnoses made endoscopically or histologically that would not have been appropriately managed by empirical therapies were seen in 16.2%. CONCLUSION: OGD in dyspepsia influences patient management in approximately one-sixth of cases. However, the majority of patients are sufficiently managed with Helicobacter pylori testing and eradication and/or a trial of proton pump inhibitor therapy. Further non-invasive approaches are needed to identify patients who need endoscopy for biopsy or therapy.
Authors: Aasma Shaukat; Amy Wang; Ruben D Acosta; David H Bruining; Vinay Chandrasekhara; Krishnavel V Chathadi; Mohamad A Eloubeidi; Robert D Fanelli; Ashley L Faulx; Lisa Fonkalsrud; Suryakanth R Gurudu; Loralee R Kelsey; Mouen A Khashab; Shivangi Kothari; Jenifer R Lightdale; V Raman Muthusamy; Shabana F Pasha; John R Saltzman; Julie Yang; Brooks D Cash; John M DeWitt Journal: Gastrointest Endosc Date: 2015-05-29 Impact factor: 9.427
Authors: Eric M Nelsen; Abby Lochmann-Bailkey; Ian C Grimes; Mark E Benson; Deepak V Gopal; Patrick R Pfau Journal: Dig Dis Sci Date: 2016-12-19 Impact factor: 3.199
Authors: Hey-Long Ching; Ailish Healy; Victoria Thurston; Melissa F Hale; Reena Sidhu; Mark E McAlindon Journal: World J Gastroenterol Date: 2018-07-14 Impact factor: 5.742
Authors: D Mark Pritchard; Jan Bornschein; Ian Beales; Ariel Beresniak; Hocine Salhi; Peter Malfertheiner Journal: BMJ Open Gastroenterol Date: 2021-07